44 year old female presented with gum bleeding since 1 week. No organomegaly was seen. The hemogram revealed hemoglobin—100 g/L, total leucocyte count—4.2 × 109/L and platelet—1500 × 109/L. Previous counts, done 2 months back were normal. Peripheral smear showed marked thrombocytosis and 41% blasts with Auer rod (Fig. 1). Marrow showed similar blasts (47%). Megakaryocytes were adequate with bizarre morphology including large and hyper lobulated forms with some showing separated nuclei (Fig. 2). Maturing myeloid and erythroid components were seen without significant dysplasia. On immunophenotyping, the blasts were positive for MPO, CD34 (weak), CD117 and were negative for HLA-DR. Cytogenetics was normal (46, XX). Molecular genetic analysis showed mutation of NPM1 (by RT-PCR) with no FLT3-ITD (by RT-PCR) mutation. Subtyping of the NPM-1 mutation could not be done due to availability issue. Underlying myeloproliferative neoplasm(MPN) was excluded with negative result for BCR-ABL1 (by multiplex PCR), JAK2 (by ARMS-PCR), calreticulin and MPL mutation. Final diagnosis of acute myeloid leukemia (AML) with mutated NPM1 was made.
Fig. 1.
Peripheral smear (× 400) showing thrombocytosis and a blast with cup shaped nucleus (a). Bone marrow (× 100) showing platelet pools and megakaryocytes (b). × 1000 shows dysplastic megakaryocytes (c). Blast with Auer rod (arrow) (d)
Fig. 2.
End of induction bone marrow biopsy × 100 showing normal cellularity (a). × 400 shows mild fibrosis with normal megakaryocytic morphology (b)
Rare cases of de novo AML with thrombocytosis in absence of any recurrent cytogenetic abnormality have been described [1]. NPM1 mutation is only rarely associated with MPN [2]. Ours is an unusual case of NPM1 mutated de-novo AML with marked thrombocytosis.
References
- 1.Chen Y, Pourabdollah M, Chang H. Acute myeloid leukemia with mutated NPM1 demonstrating multilineage dysplasia and marked thrombocytosis. Br J Haematol. 2017;178(3):350. doi: 10.1111/bjh.14741. [DOI] [PubMed] [Google Scholar]
- 2.Wang M, He N, Tian T, Liu L, Yu S, Ma D. Mutation analysis of JAK2V617F, FLT3-ITD, NPM1, and DNMT3A in Chinese patients with myeloproliferative neoplasms. Biomed Res Int. 2014;2014:485645. doi: 10.1155/2014/485645. [DOI] [PMC free article] [PubMed] [Google Scholar]


